Business Description
Genomma Lab Internacional SAB de CV
ISIN : MX01LA010006
Share Class Description:
MEX:LABB: Class BCompare
Compare
Traded in other countries / regions
LABB.MexicoGEKA.GermanyGNMLF.USA IPO Date
2008-06-18Description
Genomma Lab Internacional SAB de CV is a specialty and generic drug manufacturer. The company's stated goal is to improve and preserve the health and well-being of people through innovative, safe, and effective products. Genomma operates a wide variety of brands to serve different consumer needs, including pregnancy, pain medication, and deodorant. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.28 | |||||
| Equity-to-Asset | 0.47 | |||||
| Debt-to-Equity | 0.59 | |||||
| Debt-to-EBITDA | 1.85 | |||||
| Interest Coverage | 4.27 | |||||
| Piotroski F-Score | 8/9 | |||||
| Altman Z-Score | 3.45 | |||||
| Beneish M-Score | -2.64 | |||||
| WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 7.9 | |||||
| 3-Year EBITDA Growth Rate | 1.7 | |||||
| 3-Year EPS without NRI Growth Rate | -4.7 | |||||
| 3-Year FCF Growth Rate | 10.1 | |||||
| 3-Year Book Growth Rate | 4.7 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 28.15 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 8.61 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 72.87 | |||||
| 9-Day RSI | 63.84 | |||||
| 14-Day RSI | 61.43 | |||||
| 3-1 Month Momentum % | 25.85 | |||||
| 6-1 Month Momentum % | 61.97 | |||||
| 12-1 Month Momentum % | 101.14 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.81 | |||||
| Quick Ratio | 1.48 | |||||
| Cash Ratio | 0.27 | |||||
| Days Inventory | 120.17 | |||||
| Days Sales Outstanding | 92.9 | |||||
| Days Payable | 107.89 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 2.9 | |||||
| Dividend Payout Ratio | 0.44 | |||||
| Forward Dividend Yield % | 2.93 | |||||
| 5-Year Yield-on-Cost % | 2.9 | |||||
| 3-Year Average Share Buyback Ratio | 2.3 | |||||
| Shareholder Yield % | 8.2 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 63.56 | |||||
| Operating Margin % | 20.95 | |||||
| Net Margin % | 9.18 | |||||
| FCF Margin % | 14.6 | |||||
| ROE % | 15.54 | |||||
| ROA % | 7.31 | |||||
| ROIC % | 13.6 | |||||
| 3-Year ROIIC % | -300.36 | |||||
| ROC (Joel Greenblatt) % | 41.32 | |||||
| ROCE % | 21.3 | |||||
| Years of Profitability over Past 10-Year | 8 |
GF Value Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 16.91 | |||||
| Forward PE Ratio | 11.6 | |||||
| PE Ratio without NRI | 15.12 | |||||
| Shiller PE Ratio | 31.9 | |||||
| Price-to-Owner-Earnings | 12.02 | |||||
| PEG Ratio | 2.61 | |||||
| PS Ratio | 1.55 | |||||
| PB Ratio | 2.46 | |||||
| Price-to-Tangible-Book | 5.19 | |||||
| Price-to-Free-Cash-Flow | 10.43 | |||||
| Price-to-Operating-Cash-Flow | 10.38 | |||||
| EV-to-EBIT | 9.41 | |||||
| EV-to-Forward-EBIT | 8.09 | |||||
| EV-to-EBITDA | 8.62 | |||||
| EV-to-Forward-EBITDA | 7.11 | |||||
| EV-to-Revenue | 1.75 | |||||
| EV-to-Forward-Revenue | 1.61 | |||||
| EV-to-FCF | 12.02 | |||||
| Price-to-GF-Value | 1.52 | |||||
| Price-to-Projected-FCF | 0.88 | |||||
| Price-to-Median-PS-Value | 1.07 | |||||
| Price-to-Peter-Lynch-Fair-Value | 2.31 | |||||
| Price-to-Graham-Number | 1.87 | |||||
| Earnings Yield (Greenblatt) % | 10.63 | |||||
| FCF Yield % | 9.85 | |||||
| Forward Rate of Return (Yacktman) % | 13.47 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Genomma Lab Internacional SAB de CV Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil MXN) | 17,466.482 | ||
| EPS (TTM) (MXN) | 1.621 | ||
| Beta | 0.7 | ||
| 3-Year Sharpe Ratio | 0.3 | ||
| 3-Year Sortino Ratio | 0.48 | ||
| Volatility % | 32.15 | ||
| 14-Day RSI | 61.43 | ||
| 14-Day ATR (MXN) | 0.759728 | ||
| 20-Day SMA (MXN) | 26.644 | ||
| 12-1 Month Momentum % | 101.14 | ||
| 52-Week Range (MXN) | 12.39 - 28.39 | ||
| Shares Outstanding (Mil) | 948.05 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 8 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Genomma Lab Internacional SAB de CV Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Genomma Lab Internacional SAB de CV Stock Events
| Event | Date | Price (MXN) | ||
|---|---|---|---|---|
| No Event Data | ||||
Genomma Lab Internacional SAB de CV Frequently Asked Questions
What is Genomma Lab Internacional SAB de CV(MEX:LABB)'s stock price today?
The current price of MEX:LABB is MXN27.41. The 52 week high of MEX:LABB is MXN28.39 and 52 week low is MXN12.39.
When is next earnings date of Genomma Lab Internacional SAB de CV(MEX:LABB)?
The next earnings date of Genomma Lab Internacional SAB de CV(MEX:LABB) is 2025-02-21 Est..
Does Genomma Lab Internacional SAB de CV(MEX:LABB) pay dividends? If so, how much?
The Dividend Yield %  of Genomma Lab Internacional SAB de CV(MEX:LABB) is 2.9% (As of Today), Highest Dividend Payout Ratio of Genomma Lab Internacional SAB de CV(MEX:LABB) was 0.75. The lowest was 0.44. And the median was 0.7. The  Forward Dividend Yield % of Genomma Lab Internacional SAB de CV(MEX:LABB) is 2.93%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers